News Shortcuts from other journals

HPV vaccine stops cervical intraepithelial neoplasia

BMJ 2007; 335 doi: (Published 05 July 2007) Cite this as: BMJ 2007;335:16

Human papillomavirus (HPV) types 16 and 18 cause about 70% of cervical cancer worldwide. At least one vaccine is already available, and others are in development, including a bivalent vaccine against HPV types 16 and 18 developed by GlaxoSmithKline. The vaccine, which is a …

View Full Text

Log in

Log in through your institution


* For online subscription